Leader

Accelerate the hit-to-lead process with therapeutic antibody profiling (TAP) for antibodies and advanced drug-likeness filters for small molecules. Perform induced-fit targeted docking with proprietary protocols, AI-assisted MD simulations and analysis, per-residue binding energy, and alanine scanning calculations for in-silico optimization and validation of leads.